Skip to main content
Veterinary Medicines

SEDAXYLAN

Authorised
  • Xylazine hydrochloride

Product identification

Medicine name:
SEDAXYLAN
SEDAXYLAN 20 MG/ML SOLUTION INJECTABLE POUR CHIENS, CHATS, CHEVAUX ET BOVINS
Active substance:
  • Xylazine hydrochloride
Target species:
  • Cattle
  • Horse
  • Dog
  • Cat
Route of administration:
  • Intramuscular use
  • Intravenous use
  • Subcutaneous use

Product details

Active substance and strength:
  • Xylazine hydrochloride
    23.30
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Milk
        0
        day
      • Meat and offal
        1
        day
    • Horse
      • Meat and offal
        1
        day
    • Dog
    • Cat
  • Intravenous use
    • Cattle
      • Milk
        0
        day
      • Meat and offal
        1
        day
    • Horse
      • Meat and offal
        1
        day
    • Dog
    • Cat
  • Subcutaneous use
    • Cattle
      • Milk
        0
        day
      • Meat and offal
        1
        day
    • Horse
      • Meat and offal
        1
        day
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QN05CM92
Authorisation status:
  • Valid
Authorised in:
  • France
Package description:
  • Vial of 50 ml volume contents 50 ml. Glass type II, amber coloured. Bromobutyl rubber stopper type I secured with aluminium cap.
  • Vial of 30 ml volume contents 25 ml. Glass type II, amber coloured. Bromobutyl rubber stopper type I secured with aluminium cap.

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Eurovet Animal Health B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Eurovet Animal Health B.V.
Responsible authority:
  • National Veterinary Medicines Agency
Authorisation number:
  • FR/V/1427734 4/2003
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0106/001
Concerned member states:
  • Austria
  • Belgium
  • Denmark
  • France
  • Germany
  • Greece
  • Ireland
  • Italy
  • Luxembourg
  • Portugal
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 4/04/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."